LEADING Australian contract clinical research company Novotech, Marine Biotechnology Australia and the University of Sydney are taking part in a new herpes research collaboration backed by the Academic Research Council (ARC).

Other relevant content

September 24, 2023 News

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

Read more
July 12, 2023 News

Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023

Read more
July 10, 2023 News

Novotech Presents Technical Session on Clinical Trial Success Factors at BIOPLUS-INTERPHEX KOREA…

Read more
June 21, 2023 News

Novotech Selected for Biotech CRO Leadership Award 2023

Read more
May 29, 2023 News

Novotech Sponsors BIO 2023 APAC Summit and the Endpoints Panel on Forging Biotech Ties with China

Read more
May 26, 2023 News

Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development…

Read more
May 5, 2023 News

Industry Survey Identifies Successful Biotech Clinical Trial Strategies

Read more
April 13, 2023 News

Novotech Joins Expert Panel at AACR for eChinaHealth Session on Collaborating with China’s Cancer…

Read more
March 31, 2023 News

GlobalData Publishes FDA Regulatory Guidance and Strategy Report for Biotech Approval Pathways

Read more
November 29, 2021 News

Congratulations to the Novotech Seoul Korea team

Read more
October 8, 2021 News

Clinical Leader Announces Novotech a 2021 CRO Leadership Award Winner

Read more
September 7, 2021 News

Novotech named as one the Best Companies to Work for in Asia 2021

Read more